About Biogenesis
Biogenesis is a company based in Poole (United Kingdom) founded in 1984 was acquired by MorphoSys in January 2005. Biogenesis operates in a competitive market with competitors including GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.
- Headquarter Poole, United Kingdom
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Biogenesis Ltd
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Biogenesis
Detailed funding history for Biogenesis
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Biogenesis
Biogenesis has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include MorphoSys.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Therapeutic antibodies for cancer and other diseases are developed.
|
Locked | Locked | Locked |
Investor details for Biogenesis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biogenesis
Investment portfolio details for Biogenesis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biogenesis
Detailed financials for Biogenesis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biogenesis Comparisons
Peer comparison for Biogenesis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biogenesis
Biogenesis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Reagents and instruments are provided for life sciences research.
|
|
| Locked | Locked | Locked |
Reagents and kits are provided for clinical research applications.
|
|
| Locked | Locked | Locked |
Monoclonal antibody technology and products are developed by Epitomics.
|
|
| Locked | Locked | Locked |
Developer of antibodies for the treatment of multiple diseases
|
|
| Locked | Locked | Locked |
Antibodies and immunoassay kits are developed for research applications.
|
|
| Locked | Locked | Locked |
Antibody and vaccine culture media products are developed.
|
Detailed competitors of Biogenesis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biogenesis
Complete news archive for Biogenesis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biogenesis
Biogenesis was founded in 1984.
Biogenesis is headquartered in Poole, United Kingdom. It is registered at Poole, England, United Kingdom.
Biogenesis was founded in 1984 in Poole, United Kingdom, within the biotechnology sector. Custom antibodies were developed and commercialized by the company for life science research applications. Operations centered on the proprietary huCAL platform, which facilitated rapid and precise production of tailored antibodies. The company was acquired by MorphoSys in February 2005 for 8.6 million.
Biogenesis's top competitors include Sino Biological, GenScript and Y-Biologics.
Biogenesis has 1 investor. Key investors include MorphoSys.